Aspira Women's Health appoints Michael Buhle as CEO, James Crawford as VP of Finance

Aspira Women's Health Inc.

Michael Buhle appointed CEO, adds role to current Chief Commercial Officer duties; effective Jan 28, 2025.
James Crawford appointed VP of Finance, serving as principal financial and accounting officer; joined Aspira in 2021.
Interim CEO Dr. Sandra Milligan remains President of the Company.
No family relationships or material interests with existing directors or officers per Regulation S-K.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

James Crawford

Vice President of Finance

AWHL · Aspira Women's Health Inc.

Effective: 2025-01-28
Filed: January 31, 2025, 6:59 PM ET

In addition, on January 28, 2025, the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed James Crawford as the Company’s Vice President of Finance.

Appointed

Michael Buhle

Chief Executive Officer

AWHL · Aspira Women's Health Inc.

Effective: 2025-01-28
Filed: January 31, 2025, 6:59 PM ET

On January 28, 2025, the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed Michael Buhle as the Company’s Chief Executive Officer in addition to his current duties as Chief Commercial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Crawford was appointed as Vice President of Finance at Aspira Women's Health Inc..

Action: appointed
Role: Vice President of Finance

Exact text from the filing

In addition, on January 28, 2025, the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed James Crawford as the Company’s Vice President of Finance.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Buhle was appointed as Chief Executive Officer at Aspira Women's Health Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On January 28, 2025, the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed Michael Buhle as the Company’s Chief Executive Officer in addition to his current duties as Chief Commercial Officer.

View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-004329

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.